CMC & Manufacturing

Process Validation(PV)

Documented evidence that a process consistently produces a product meeting predetermined specifications and quality attributes.

Usage Examples

Process validation included three PPQ batches.
CPV data showed the process remained in control.
Validation demonstrated consistent tablet hardness.

What is PV?

Process Validation is the collection and evaluation of data that establishes scientific evidence that a process is capable of consistently delivering quality product. The FDA guidance (2011) describes a lifecycle approach with three stages.

Stage 1 (Process Design): Establish commercial process based on development and scale-up. Stage 2 (Process Qualification): Confirm process design through prospective validation batches. Stage 3 (Continued Process Verification): Ongoing monitoring during routine production.

Traditional validation required three consecutive successful batches. Modern approaches emphasize understanding process variability and may use statistical methods to determine appropriate batch numbers.

Regulatory Context

This term appears most often in cmc & manufacturing workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 211, FDA PROCESS VALIDATION GUIDANCE, ICH Q8.

FDAICHHealth Canada

When This Matters

Process validation included three PPQ batches.
CPV data showed the process remained in control.
Validation demonstrated consistent tablet hardness.

Common Mistakes

Failing to align CMC change narratives with current CFR/ICH expectations.
Submitting incomplete control strategy documentation.
Separating manufacturing and regulatory review cycles too late in execution.

Related Regulations

21 CFR 211FDA PROCESS VALIDATION GUIDANCEICH Q8ICH Q9ICH Q10

Frequently Asked Questions

The FDA lifecycle approach doesn't mandate exactly three batches. The number should be justified based on process understanding, variability, and statistical confidence required.

Significant changes to equipment, process parameters, raw materials, manufacturing site, or scale may require revalidation. The extent depends on risk assessment of the change.